Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SAN-711 by Saniona for Epilepsy: Likelihood of Approval
SAN-711 is under clinical development by Saniona and currently in Phase I for Epilepsy. According to GlobalData, Phase I drugs...